College of Traditional Chinese Medicine, Changchun University of Traditional Chinese Medicine, Changchun, China.
Guang'an Men Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Front Endocrinol (Lausanne). 2024 Feb 14;15:1336123. doi: 10.3389/fendo.2024.1336123. eCollection 2024.
Diabetic nephropathy (DN) and diabetic retinopathy (DR), as microvascular complications of diabetes mellitus, are currently the leading causes of end-stage renal disease (ESRD) and blindness, respectively, in the adult working population, and they are major public health problems with social and economic burdens. The parallelism between the two in the process of occurrence and development manifests in the high overlap of disease-causing risk factors and pathogenesis, high rates of comorbidity, mutually predictive effects, and partial concordance in the clinical use of medications. However, since the two organs, the eye and the kidney, have their unique internal environment and physiological processes, each with specific influencing molecules, and the target organs have non-parallelism due to different pathological changes and responses to various influencing factors, this article provides an overview of the parallelism and non-parallelism between DN and DR to further recognize the commonalities and differences between the two diseases and provide references for early diagnosis, clinical guidance on the use of medication, and the development of new drugs.
糖尿病肾病 (DN) 和糖尿病视网膜病变 (DR) 作为糖尿病的微血管并发症,分别是目前成年劳动力人群中终末期肾病 (ESRD) 和失明的主要原因,它们是具有社会和经济负担的主要公共卫生问题。两者在发生和发展过程中的平行性表现在致病风险因素和发病机制的高度重叠、高合并率、相互预测作用以及药物临床应用的部分一致性。然而,由于眼睛和肾脏这两个器官具有独特的内部环境和生理过程,每个器官都有特定的影响分子,并且由于不同的病理变化和对各种影响因素的反应不同,靶器官也没有平行性,因此本文概述了 DN 和 DR 之间的平行性和非平行性,以进一步认识这两种疾病的共性和差异,为早期诊断、药物临床应用指导以及新药开发提供参考。